Xi Chen

KOKA Lifesciences Co., Ltd. is a high-tech enterprise based in Shanghai, CN that specializes in the research, production, and sales of medical devices for structural heart disease. KOKA Lifesciences has applied for nearly 30 patents and has about 2,000 square meters of 10,000-level clean production workshops, 1,000 square meters of Shanghai R&D Center, and more than 80 sets of testing equipment. The Chinese company develops systematic solutions for valvular disease for different populations and scenarios, with each product having its own intellectual property rights. The company's production equipment includes wire cutting, multi-functional machine tools, laser welding machine, laser cutting machine, automatic polishing machine, high-temperature heat setting machine, valve covering machine, and other precision processing equipment, which can realize from raw material to product integration independent production pattern. The company also has valve fatigue test, valve pulsatile flow test, high-performance gas chromatograph, and other high-end precision testing equipment to strictly test and control the key quality characteristics of products. The company was founded in 2018, and the CEO is Ming Ming Wu.